NCT03110809 (BATCAP) is a NA clinical trial of Capsinoid in Weight Loss, sponsored by Northwestern University.

Who is sponsoring NCT03110809?

NCT03110809 is sponsored by Northwestern University.

What drugs are being tested in NCT03110809?

Interventions in NCT03110809: Capsinoid, Placebo.

What condition does NCT03110809 study?

NCT03110809 studies Weight Loss.

Is NCT03110809 still recruiting?

NCT03110809 is currently completed. Last updated 14 December 2021.

Last reviewed 2021-12-14 · How we verify

NCT03110809: BATCAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effects of Capsinoids on Brown Adipose Tissue Activation in Obesity

Completed NA Last updated 14 December 2021

What this trial tests

NA trial testing Capsinoid in Weight Loss in 19 participants. Completed in 13 August 2021.

Timeline

17 April 2017

Primary endpoint
13 August 2021

13 August 2021

Quick facts

Lead sponsor	Northwestern University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	other
Enrollment	19
Start date	17 April 2017
Primary completion	13 August 2021
Estimated completion	13 August 2021
Sites	1 location across United States

Drugs / interventions tested

Capsinoid
Placebo

Conditions studied

Weight Loss — all drugs for Weight Loss →

Sponsor

Northwestern University

Who can join

Adults 18 to 50, male only, with Weight Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study is being done to determine whether taking a dietary supplement called capsinoids, derived from sweet peppers, can activate brown fat that is already present or even generate new brown fat in individuals with excess weight. Previous studies have suggested that chronic consumption of capsinoids may be able to generate new brown fat in thin individuals. Capsinoids may also have a small positive effect on metabolism (increased calorie-burning) and fat loss. The knowledge gained in this study may eventually lead to more treatment options for people with excess weight.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The evolving view of thermogenic fat and its implications in cancer and metabolic diseases.
Yin X, Chen Y, Ruze R, Xu R, et al · · 2022 · cited 43× · PMID 36114195 · DOI 10.1038/s41392-022-01178-6

Verify or expand the search:

Other recruiting trials for Weight Loss

Currently open trials in the same condition.

NCT06811324 — Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults · Phase 2 · recruiting
NCT07223983 — Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS) · Phase 1 · recruiting
NCT07213466 — Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder · Phase 4 · recruiting
NCT06785064 — Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance · NA · recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting

Other Northwestern University trials

Trials by the same sponsor.

NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03110809 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwestern University
Last refreshed: 14 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03110809.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing